Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 1 of 1 drugs
| No. | KEGG DRUG | DrugBank | 薬物名（臨床試験情報から抽出） | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
Bevacizumab
1. Bevacizumab
(Bevacizumab (USAN), Bevacizumab (genetical recombination) (JAN), Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN), Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN), Bevacizumab (genetical recombination) [Bevacizumab biosimilar 3] (JAN), Bevacizumab (genetical recombination) [Bevacizumab biosimilar 4] (JAN), Bevacizumab-awwb, Bevacizumab-bvzr) | 1件: Bevacizumab Bevacizumab (bevacizumab-awwb) | 2件: AVASTIN AVASTIN; Bevacizumab | 1件: VEGFA VEGFA 💬1. Bevacizumab
| 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway ... | 6件: 13 13, 34, 85, 87, 227, 280 💬1. Bevacizumab
|